Skip to content
2000
image of Aptamer-Decorated Nanocarrier for Selectively Targeting Cancer Cells

There is no abstract available.

Loading

Article metrics loading...

/content/journals/pnt/10.2174/0122117385372567250304072634
2025-03-12
2025-09-26
Loading full text...

Full text loading...

/deliver/fulltext/pnt/10.2174/0122117385372567250304072634/BMS-PNT-2024-181.html?itemId=/content/journals/pnt/10.2174/0122117385372567250304072634&mimeType=html&fmt=ahah

References

  1. Shangguan D. Meng L. Cao Z.C. Xiao Z. Fang X. Li Y. Cardona D. Witek R.P. Liu C. Tan W. Identification of liver cancer-specific aptamers using whole live cells. Anal. Chem. 2008 80 3 721 728 10.1021/ac701962v 18177018
    [Google Scholar]
  2. Gopinath S.C.B. Methods developed for SELEX. Anal. Bioanal. Chem. 2007 387 1 171 182 10.1007/s00216‑006‑0826‑2 17072603
    [Google Scholar]
  3. Dai B. Hu Y. Duan J. Yang X.D. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells. Oncotarget 2016 7 25 38257 38269 10.18632/oncotarget.9431 27203221
    [Google Scholar]
  4. Ma Y. Li W. Zhou Z. Qin X. Wang D. Gao Y. Yu Z. Yin F. Li Z. Peptide-Aptamer coassembly nanocarrier for cancer therapy. Bioconjug. Chem. 2019 30 3 536 540 10.1021/acs.bioconjchem.8b00903 30702869
    [Google Scholar]
  5. Carvalho J. Paiva A. Cabral Campello M.P. Paulo A. Mergny J.L. Salgado G.F. Queiroz J.A. Cruz C. Aptamer-based targeted delivery of a g-quadruplex ligand in cervical cancer cells. Sci. Rep. 2019 9 1 7945 10.1038/s41598‑019‑44388‑9 31138870
    [Google Scholar]
  6. Yan J. Bhadane R. Ran M. Ma X. Li Y. Zheng D. Salo-Ahen O.M.H. Zhang H. Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy. Nat. Commun. 2024 15 1 3684 10.1038/s41467‑024‑48149‑9 38693181
    [Google Scholar]
  7. Taghizadeh-Tabarsi R. Akbari-Birgani S. Amjadi M. Mohammadi S. Nikfarjam N. Kusamori K. Aptamer-guided graphene oxide quantum dots for targeted suicide gene therapy in an organoid model of luminal breast cancer. Sci. Rep. 2024 14 1 24104 10.1038/s41598‑024‑74312‑9 39406784
    [Google Scholar]
/content/journals/pnt/10.2174/0122117385372567250304072634
Loading
/content/journals/pnt/10.2174/0122117385372567250304072634
Loading

Data & Media loading...


  • Article Type:
    Editorial
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test